Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting
How Neuland successfully transferred, validated, and commercialized the manufacturing of a novel API while navigating COVID-19 lockdowns, workforce restrictions, and global supply chain challenges.
In this case study, discover how Neuland partnered with Esperion Therapeutics to expand the commercial supply of Bempedoic Acid, the active pharmaceutical ingredient in NEXLETOL® and NEXLIZET®. Despite unprecedented pandemic-related disruptions, Neuland executed a seamless technology transfer, completed process validation, supported global regulatory filings, and established a reliable commercial manufacturing program through proactive planning, virtual collaboration, and supply chain resilience.
This case study highlights how effective technology transfer, proactive risk management, and manufacturing agility enabled uninterrupted development and commercialization activities during one of the most challenging periods in modern pharmaceutical manufacturing.